The venture capital funds managed by Matignon Investissement & Gestion are dedicated to investments in unlisted, innovative early-stage companies specialised in high technologies with strong growth potential. Amounts invested in one specific company vary between 0.5 and 8 M€.

We have a very open approach to new technologies and look at investments in both French and European companies in areas ranging from medical technologies, IT, media, telecommunications and life sciences. We devote our efforts in particular to areas in which we are best able to build up added value for the companies in which we invest i.e. medical technologies, medical devices, corporate software and high value added services.

We give priority to companies which have already financed the major part of their R&D process and which wish to launch or accelerate their commercial development. We pay particular attention to the coherency of the company\\\\\\\'s commercial strategy and the degree of quality at which this strategy is carried out.